Biochemistry of neuroendocrine tumours

被引：102

作者：

de Herder, Wouter W. ^{[1
]}

机构：

[1] Erasmus MC, Dept Internal Med, Sector Endocrinol, NL-3015 GCE Rotterdam, Netherlands

来源：

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 21卷 / 01期

关键词：

serotonin; 5-HIAA; carcinoid; insulinoma; gastrinoma; VIPoma; glucagonoma; somatostatinoma; chromogranins; neuron-specific enolase (NSE); alpha-subunits of the glycoprotein hormones; catecholamines; pancreatic polypeptide (PP); ghrelin; adrenomedullin;

D O I：

10.1016/j.beem.2006.12.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several circulating or urinary tumour markers can be used for the diagnosis and follow-up of functioning and clinically non-functioning neuroendocrine tumours of the pancreatic islet cells and intestinal tract. Among the specific tumour markers are serotonin and its metabolites e.g. 5-hydroxyindoleacetic acid (5-HIAA) - in carcinoid tumours and the carcinoid syndrome, insulin and its precursors or breakdown products in insulinoma, and gastrin in gastrinoma. Plasma vasointestinal polypeptide (VIP) determinations have been used in the diagnosis of VIPoma, plasma glucagon for glucagonoma, and serum somatostatin for somatostatinoma. Among the tumour-non-specific markers are: chromogranins, neuron-specific enolase (NSE), alpha-subunits of the glycoprotein hormones, catecholamines, pancreatic polypeptide (PP), ghrelin and adrenomedullin.

引用

页码：33 / 41

页数：9

共 50 条

[41] ASSESSMENT OF IMMUNOASSAYS FOR INSULIN IN DIAGNOSTIC-TESTS FOR INSULINOMA [J].

SHIMIZU, T ;

SASAKUMA, F ;

ISHIKAWA, O ;

MATSUMIYA, K ;

HASEGAWA, K ;

SASAKI, A .

DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 26 (02) :149-154

[42] A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B [J].

Stridsberg, M ;

Eriksson, B ;

Öberg, K ;

Janson, ET .

REGULATORY PEPTIDES, 2005, 125 (1-3) :193-199

[43] MEASUREMENTS OF CHROMOGRANIN-A, CHROMOGRANIN-B (SECRETOGRANIN-I), CHROMOGRANIN-C (SECRETOGRANIN-II) AND PANCREASTATIN IN PLASMA AND URINE FROM PATIENTS WITH CARCINOID-TUMORS AND ENDOCRINE PANCREATIC TUMORS [J].

STRIDSBERG, M ;

OBERG, K ;

LI, Q ;

ENGSTROM, U ;

LUNDQVIST, G .

JOURNAL OF ENDOCRINOLOGY, 1995, 144 (01) :49-59

[44]

Stridsberg Mats, 1995, Upsala Journal of Medical Sciences, V100, P169

[45] Malignant gastric ghrelinoma with hyperghrelinemia [J].

Tsolakis, AV ;

Portela-Gomes, GM ;

Stridsberg, M ;

Grimelius, L ;

Sundin, A ;

Eriksson, BK ;

Öberg, KE ;

Janson, ET .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3739-3744

[46] Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours [J].

Turner, G. B. ;

Johnston, B. T. ;

McCance, D. R. ;

McGinty, A. ;

Watson, R. G. P. ;

Patterson, C. C. ;

Ardill, J. E. S. .

GUT, 2006, 55 (11) :1586-1591

[47] Adult hyperinsulinemic hypoglycemia not caused by an insulinoma: a report of two cases [J].

van der Wal, BCH ;

de Krijger, RR ;

de Herder, WW ;

Kwekkeboom, DJ ;

van der Ham, F ;

Bonjer, HJ ;

van Eijck, CHJ .

VIRCHOWS ARCHIV, 2000, 436 (05) :481-486

[48] Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism [J].

Vezzosi, D ;

Bennet, A ;

Fauvel, J ;

Boulanger, C ;

Tazi, O ;

Louvet, JP ;

Caron, P .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (05) :413-419

[49] Assessment of hyperinsulinaemia at the termination of the prolonged fast [J].

Wiesli, P ;

Brändle, M ;

Zapf, R ;

Seiler, H ;

Zwimpfer, C ;

Spinas, GA ;

Schmid, C .

CLINICA CHIMICA ACTA, 2004, 342 (1-2) :227-231

[50] Carcinoid heart disease -: The role of urinary 5-hydroxyindoleacefic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor [J].

Zuetenhorst, JM ;

Bonfrer, JMGM ;

Korse, CM ;

Bakker, R ;

van Tinteren, H ;

Taal, BG .

CANCER, 2003, 97 (07) :1609-1615

← 1 2 3 4 5 →